Abbott India Ltd.
NSE: ABBOTINDIA | BSE: 500488
₹25,260.00
₹0.00 (0.00%)As on 11-Sep-2026 09:08IST
Market cap
₹53,703 Cr
Revenue (TTM)
₹7,004 Cr
P/E Ratio
33.3
P/B Ratio
10.4
Div. Yield
2.6 %
Quality Score
10/10
Growth Score
7/10
Valuation Score
5/10
Momentum Score
2/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹1,615 Cr
-
ROE
34.7 %
-
ROCE
46.7 %
-
Industry P/E
35.03
-
EV/EBITDA
22.8
-
Debt to Equity
0
-
Book Value
₹2435.9
-
EPS
₹759.9
-
Face value
10
-
Shares outstanding
21,249,302
10 Years Aggregate
CFO
₹7,696.86 Cr
EBITDA
₹10,519.56 Cr
Net Profit
₹8,327.61 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Abbott India
| -13.0 | -8.3 | -4.5 | -19.2 | 3.2 | 4.1 | 18.4 |
|
BSE Healthcare
| 17.3 | -0.5 | 8.4 | 14.0 | 21.7 | 14.0 | 11.9 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Abbott India
| -3.3 | 30.7 | 6.9 | 9.7 | 23.7 | 20.0 | 72.5 |
|
BSE Mid Cap
| 1.1 | 25.8 | 45.5 | 1.4 | 39.2 | 19.9 | -3.0 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Abbott India
|
25,260.0 | 53,702.5 | 7,004.4 | 1,614.7 | 27.0 | 36.8 | 33.3 | 10.4 |
| 5,122.0 | 61,100.1 | 15,081.3 | 2,206.3 | 17.5 | 16.8 | 28.3 | 4.3 | |
| 1,666.7 | 96,030.6 | 34,935.3 | 3,712.7 | 15.0 | 10.4 | 25.9 | 2.5 | |
| 391.6 | 63,558.1 | 17,321.1 | 416.4 | 8.6 | -0.2 | 128.3 | 1.9 | |
| 1,130.0 | 95,220.3 | 33,227.9 | 3,169.3 | 9.1 | 8.7 | 29.6 | 2.5 | |
| 2,840.9 | 48,124.9 | 3,954.9 | 1,068.2 | 32.5 | 53 | 45.1 | 19.1 | |
| 1,975.8 | 49,982.3 | 10,125.6 | 1,379.8 | 17.8 | 17.7 | 38.2 | 5.9 | |
| 2,064.0 | 94,882.7 | 29,966.6 | 5,551.0 | 26.7 | 28.3 | 17.2 | 4.0 | |
| 2,237.2 | 92,769.9 | 14,737.9 | 2,055.1 | 19.9 | 13.6 | 45.4 | 5.5 | |
| 1,114.0 | 1,11,520.9 | 28,591.7 | 4,492.2 | 19.3 | 18.8 | 24.7 | 4.1 |
Shareholding Pattern
View DetailsNews & Analysis
All News
10 rock-solid stocks with stable earnings
17 min read•By Udhayaprakash, Mithilesh Bhaumik, Shubham Dilawari and Kunal Bansal
Stock Rating update, March 22, 2024
2 min read•By Value Research
2 min read•By Value Research
About Abbott India
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, hypothyroidism, central nervous system, vaccines, and... multispecialty, including insomnia, vertigo, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited. Read more
-
Incorporated
1944
-
Chairman
Sudarshan Jain
-
Managing Director
Kartik Rajendran
-
Group
Abbott India - MNC
-
Headquarters
Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Abbott India
What is the current share price of Abbott India Ltd Today?
The share price of Abbott India Ltd is ₹25,260.00 (NSE) and ₹25,224.70 (BSE) as of 11-Sep-2026 09:08 IST. Abbott India Ltd has given a return of 3.17% in the last 3 years.
What is the current PB & PE ratio of Abbott India Ltd?
The P/E ratio of Abbott India Ltd is 33.26 times as on 10-Sep-2026, a 5 discount to its peers’ median range of 35.03 times.
The P/B ratio of Abbott India Ltd is 10.37 times as on 10-Sep-2026, a 101 premium to its peers’ median range of 5.17 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
35.49 |
11.60 |
2025 |
46.17 |
15.53 |
2024 |
47.67 |
15.65 |
2023 |
49.43 |
14.92 |
2022 |
47.09 |
13.55 |
What is the 52 Week High and Low of Abbott India Ltd?
The 52-week high and low of Abbott India Ltd are Rs 31,495.00 and Rs 25,150.00 as of 11-Sep-2026.
What is the market cap of Abbott India Ltd?
Abbott India Ltd has a market capitalisation of ₹ 53,703 Cr as on 10-Sep-2026. As per SEBI classification, it is a Mid Cap company.
Should I invest in Abbott India Ltd?
Before investing in Abbott India Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.